l-carnitine for mitochondrial disease The carnitine system and cancer metabolic plasticity L-Carnitine and Acylcarnitines: Mitochondrial Biomarkers

In the hepatic metabolome, we noticed alterations in certain lipid metabolites, such as acylcarnitines or phosphatidylcholines, occurring before the onset of obesity, reminiscent of similar (and hitherto unexplained) changes detected in the serum of obese AS patients 39

Carnitine is a central metabolite in the mitochondrial carnitine cycle/fatty acid oxidation pathway, in the transfer to mitochondria of the end products of peroxisomal fatty acid oxidation, and in Coenzyme A homeostasis

doi: 10.1016/j.bbrc.2018.02.063

This important review article by Dev and colleagues references ROMANA 1 and ROMANA 2, the most recently published phase III trials testing anamorelin for cancer cachexia

First, its prevalenceL-carnitine is a ingredient, included in 18% of dog food formulas